Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001204459-11-003257
Filing Date
2011-12-09
Accepted
2011-12-09 09:21:49
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10k.htm 10-K 388861
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 7166
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 7150
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2066
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 2053
  Complete submission text file 0001204459-11-003257.txt   2235786

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alrx-20110930.xml EX-101.INS 291540
7 XBRL TAXONOMY EXTENSION SCHEMA alrx-20110930.xsd EX-101.SCH 15413
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrx-20110930_cal.xml EX-101.CAL 31760
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrx-20110930_def.xml EX-101.DEF 114370
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrx-20110930_lab.xml EX-101.LAB 133442
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrx-20110930_pre.xml EX-101.PRE 125919
Mailing Address 168 KONRAD CRESCENT SUITE 200 MARKHAM A6 V6E2K3
Business Address 168 KONRAD CRESCENT SUITE 200 MARKHAM A6 V6E2K3 (905) 479-3245
ALPHARX INC (Filer) CIK: 0001114936 (see all company filings)

EIN.: 980177440 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-30813 | Film No.: 111252183
SIC: 2834 Pharmaceutical Preparations